Profile for lanchardgoldmepenfreal
|
SignatureRISPERDAL CONSTA ® (risperidone) LONG-ACTING INJECTION Initial U.S. Approval: 2003. Warning: increased mortality inRISPERDAL CONSTA® is indicated as monotherapy or as adjunctive therapy to lithium or valproate for the maintenance treatment of Bipolar I Disorder [see canadapharmaceutics.com...
|
